Evaluation of an innovative outpatient palliative care model for patients with advanced cancer: a multicenter randomized clinical trial

As European healthcare increasingly relies on outpatient services, including palliative care, additional ambulatory options are needed to meet demand. The rising complexity and scope of patients’ palliative care needs call for new outpatient tools. Our study evaluates the impact of an innovative palliative care clinic on health status in adults with advanced cancer. A superiority multicenter randomized clinical trial comparing an innovative palliative care day hospital (intervention arm) with traditional outpatient palliative care clinics (standard arm) over a six month-period. Adults with solid tumors newly referred to outpatient palliative care at six centers were enrolled, with the option to nominate a primary caregiver for caregiver needs assessment. The primary outcome was health-related quality-of-life deterioration–free survival, assessed using the EORTC Core Quality of Life questionnaire (QLQ-C30). Secondary outcomes included anxiety and depression symptoms, satisfaction with care, indicators of aggressive end-of-life care, overall survival, and caregivers’ supportive care needs among those with an identified primary caregiver. Exploratory outcomes included advance care planning discussions and patients’ perceptions of prognosis and treatment goals. Among 139 participants (mean age 67 years; 70% female; 31% breast cancer) randomized to the intervention (n = 70) or standard arm (n = 69), 34 (48.7%) and 33 (47.1%), respectively, designated a caregiver. The primary outcome was negative (p > 0.05). Over time, secondary endpoints showed a significant decrease in depression scores in the interventional arm (mean difference: − 2.30; 95% CI: − 4.57 to − 0.04; p = 0.046), while the standard arm had significantly lower psychological/emotional needs (mean difference: 0.50; 95% CI: 0.15–0.99; p = 0.044) and communication/family support needs (mean difference: 0.27; 95% CI: 0.01–0.52; p = 0.043). No significant differences were found in satisfaction with care, supportive care needs, aggressive end-of-life care, advance care planning, prognosis perception, or overall survival. Access to a palliative care day hospital did not improve HRQoL deterioration-free survival or most secondary outcomes versus traditional outpatient palliative care. Its role may therefore be best targeted to patients with particularly complex or high-intensity palliative care needs. NCT04604873 in the registry IDRCB 2019-A03116–51. Date of registration: October 27, 2020.

Authors

Institutions

Publication Details

Journal
BMC Palliative Care
Published
2026-11-21
DOI
https://doi.org/10.1186/s12904-026-02447-9
Primary Topic
Palliative Care and End-of-Life Issues
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Evaluation of an innovative outpatient palliative care model for patients with advanced cancer: a multicenter randomized clinical trial

Amélie Anota, A. De Moura, Damien Heitz, Eva Kerrouault et al.
BMC Palliative Care
Palliative Care and End-of-Life Issues
article

Evaluation of an innovative outpatient palliative care model for patients with advanced cancer: a multicenter randomized clinical trial

Amélie Anota, A. De Moura, Damien Heitz, Eva Kerrouault, Ophélie Soulié, Mathilde Trosdorf, Matthieu de Stampa, Carole Bouleuc, Laura Marret, Aurélia Meurisse, Elise Gilbert, Sophie Morin
article en

Abstract

As European healthcare increasingly relies on outpatient services, including palliative care, additional ambulatory options are needed to meet demand. The rising complexity and scope of patients’ palliative care needs call for new outpatient tools. Our study evaluates the impact of an innovative palliative care clinic on health status in adults with advanced cancer. A superiority multicenter randomized clinical trial comparing an innovative palliative care day hospital (intervention arm) with traditional outpatient palliative care clinics (standard arm) over a six month-period. Adults with solid tumors newly referred to outpatient palliative care at six centers were enrolled, with the option to nominate a primary caregiver for caregiver needs assessment. The primary outcome was health-related quality-of-life deterioration–free survival, assessed using the EORTC Core Quality of Life questionnaire (QLQ-C30). Secondary outcomes included anxiety and depression symptoms, satisfaction with care, indicators of aggressive end-of-life care, overall survival, and caregivers’ supportive care needs among those with an identified primary caregiver. Exploratory outcomes included advance care planning discussions and patients’ perceptions of prognosis and treatment goals. Among 139 participants (mean age 67 years; 70% female; 31% breast cancer) randomized to the intervention (n = 70) or standard arm (n = 69), 34 (48.7%) and 33 (47.1%), respectively, designated a caregiver. The primary outcome was negative (p > 0.05). Over time, secondary endpoints showed a significant decrease in depression scores in the interventional arm (mean difference: − 2.30; 95% CI: − 4.57 to − 0.04; p = 0.046), while the standard arm had significantly lower psychological/emotional needs (mean difference: 0.50; 95% CI: 0.15–0.99; p = 0.044) and communication/family support needs (mean difference: 0.27; 95% CI: 0.01–0.52; p = 0.043). No significant differences were found in satisfaction with care, supportive care needs, aggressive end-of-life care, advance care planning, prognosis perception, or overall survival. Access to a palliative care day hospital did not improve HRQoL deterioration-free survival or most secondary outcomes versus traditional outpatient palliative care. Its role may therefore be best targeted to patients with particularly complex or high-intensity palliative care needs. NCT04604873 in the registry IDRCB 2019-A03116–51. Date of registration: October 27, 2020.

BMC Palliative Care
Inserm (FR), Université Paris Cité (FR), Université Paris-Saclay (FR), Centre Hospitalier Universitaire de Besançon (FR), Institut de Cancérologie Strasbourg (FR), Sorbonne Paris Cité (FR), Methodology and Quality of Life Unit in Oncology (FR), Centre de recherche en Epidémiologie et Santé des Populations (FR), Centre Léon Bérard (FR), Institut de Cancérologie de l'Ouest (FR), Institut Bergonié (FR), Centre Antoine Lacassagne (FR), Institut Curie (FR)
Institut National Du Cancer
Good health and well-being
Palliative Care and End-of-Life Issues
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon